Treatment with a "polypill" that combines multiple medications into a single daily dose significantly enhanced cardiac ...

Leading cardiovascular societies have developed the second universal definition of heart failure that updates how it is classified and identified, hoping to improve diagnosis and management.

NICE has recommended a nonsteroidal mineralocorticoid receptor antagonist that lowers worsening heart failure events in adults with preserved or mildly reduced ejection fraction.

Thousands of people in England with a type of chronic heart failure are eligible for a new treatment option following our final draft guidance that recommends finerenone for adults with chronic heart ...

Heart failure (HF) imposes a large and growing burden on the population, with a prevalence that is projected to increase to more than 8 million adults by 2030. The high risk of morbidity and mortality ...

Cardiac remodelling encompasses the structural and functional alterations that the myocardium undergoes in response to injury, pressure overload or neurohormonal activation. These changes include ...

Favourable safety profile in marked contrast to traditional inotropic therapeuticsAC01 showed rapid and sustained numerical improvements in cardiac output, structure and function STOCKHOLM, Sweden, ...

Thousands of people in England and Wales with a type of chronic heart failure (CHF) could soon be eligible for treatment with ...

BACKGROUND: Metabolic adaptation and maladaptation are hallmarks of the failing heart and may be a target for therapeutic ...

A newly published international consensus is set to reshape how heart failure is diagnosed, formally recognizing non-invasive measurement of elevated cardiac filling pressure as evidence sufficient to ...

Warning symptoms, recurrent heart events may identify people at risk for this often-deadly event. Two studies from ...